Sepsis: all 1,946 studies

Page 15 of 20. Open to participants first (471), then studies with results posted, then the rest; newest registration first within each.

• Impact of Dedicated Hygienist Staff on the Occurrence of Intensive Care Unit -Aquired Bloodstream InfectionsCompletedNCT02891902
• Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic ImplicationsCompletedNCT02890901
• Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream InfectionsTerminatedNCT02890875Not applicable
• Administration of Amino-glycoside in ICU Patients : Clinical Practices in 2013CompletedNCT02888470
• Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe SepsisStatus unknownNCT02887274
• Chorioamnionitis: Observation of at Risk Infants vs Standard CareWithdrawnNCT02886910Not applicable
• Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe SepsisWithdrawnNCT02885688Phase 2
• Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for SepsisCompletedNCT02883595Phase 4
• Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis PatientsCompletedNCT02883218
• Application of Biomarkers Change to Predict Outcome of Patient With Severe SepsisStatus unknownNCT02871895
• Predictive Value of Dynamic Combination of BNP and NGAL for the Prognosis of Patients With SepsisCompletedNCT02871544Not applicable
• Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract InfectionTerminatedNCT02871024Not applicable
• The Efficacy and Safety of Ta1 for SepsisCompletedNCT02867267Phase 3
• Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a DatabaseCompletedNCT02863978Not applicable
• Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.CompletedNCT02852902
• Pediatric Immune Response to Infectious ShockCompletedNCT02848144Not applicable
• Regression Discontinuity Design to Evaluate of Drotrecogin Alpha EffectivenessCompletedNCT02843685
• Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of InfectionStatus unknownNCT02842437Not applicable
• Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Sepsis-induced Myocardial InjuryStatus unknownNCT02835573
• Quality Improvement in Infection COntrol and Sepsis Management in MOdel RegionsCompletedNCT02820675Not applicable
• BIP CVC Clinical Safety and Performance StudyCompletedNCT02811380Phase 4
• Immune Reconstitution of Immunosuppressed Sepsis PatientsTerminatedNCT02797431Phase 2
• Effect of Enteral Genistein Supplementation in SepsisStatus unknownNCT02796794Phase 4
• The Effect of Esmolol on Clinical Prognosis of Patients With Severe SepsisCompletedNCT02794025Not applicable
• Neonatal Vancomycin TrialTerminatedNCT02790996Phase 2
• Dysfunctions of Human Muscle Stem Cells in SepsisCompletedNCT02789995Not applicable
• Study of Progression of Community Acquired Pneumonia in the HospitalCompletedNCT02782013
• The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe SepsisCompletedNCT02777606Not applicable
• the Effect of Gut Microbiota on the Prognosis of SepsisStatus unknownNCT02768324
• MR-Evaluation of Renal Function In Septic PatientsCompletedNCT02765191Not applicable
• Clinical Score Usefulness and EHR IntegrationCompletedNCT02755025
• Fluids in Sepsis and Septic ShockCompletedNCT02748382Phase 2/3
• Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT)Status unknownNCT02743585Not applicable
• Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk AssessmentActive, not recruitingNCT02741986
• Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy SubjectsCompletedNCT02739373Phase 1
• TRIAGE: TRIage of Sepsis At emerGency dEpartmentCompletedNCT02739152
• SEPSIS 3 Critera for Risk Stratification in Emergency PatientsCompletedNCT02738164
• (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in SepsisCompletedNCT02734550Not applicable
• Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic ShockCompletedNCT02730624Phase 4
• SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing AssayCompletedNCT02730468
• Genotypes and Phenotypes in Pediatric SIRS and SepsisCompletedNCT02728401
• Comparison of Colloid (20% Albumin) Versus Crystalloid (Plasmalyte) for Fluid Resuscitation in Cirrhotics With Sepsis Induced Hypotension.CompletedNCT02721238Not applicable
• Diagnostic Performance of a New Bio-marker During Bacterial SepsisCompletedNCT02721134Not applicable
• Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care and Induced FrailtyCompletedNCT02711709
• Biomarkers for the Early Identification of Sepsis in the Emergency DepartmentCompletedNCT02707718
• The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRSTerminatedNCT02704871
• Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of SepsisWithdrawnNCT02699905
• IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating CentresCompletedNCT02689193
• Vitamin D Status in Patients With Severe SepsisWithdrawnNCT02684487Phase 3
• Optimizing Clinical Use of Polymyxin BCompletedNCT02682355
• Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of MelioidosisCompletedNCT02668406
• L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney InjuryTerminatedNCT02664753Phase 3
• COrporeal Compression at the ONset of Severe Sepsis and Septic ShockCompletedNCT02656654Not applicable
• Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.CompletedNCT02655133Phase 2
• Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular CoagulationStatus unknownNCT02654561Phase 3
• Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in ChinaCompletedNCT02647554Phase 4
• Utility of Presepsin in Children SepsisStatus unknownNCT02643121
• Preliminary Research On Two-step Dosing Of Imipenem/CilastatinStatus unknownNCT02616354Phase 4
• Elimination of Antibiotics During Renal Replacement Therapy and Cytosorb Adsorptive TherapyStatus unknownNCT02611271
• Efficacy of Umbilical Cord Cleansing With a Single Application of 4% Chlorhexidine for the Prevention of Newborn Infections in Uganda: a Randomized Controlled TrialCompletedNCT02606565Phase 4
• Early Versus Late BCG Vaccination in HIV-1 Exposed Infants in Uganda in UgandaCompletedNCT02606526Phase 3
• Midkine and ACE-Ang II Induced Endothelial Injury in SepsisCompletedNCT02605681
• Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of SepsisTerminatedNCT02602210Phase 3
• Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young AdultsWithdrawnNCT02599844
• Severe Sepsis in Children - IMPRESS-CWithdrawnNCT02598674
• SEPREVEN: a Stepped-wedge Randomised Controlled TrialCompletedNCT02598609Not applicable
• Circulating Stem Cells, SDF-1, HIF-1 and Sepsis's Indices in Emergency Abdominal Surgical PatientsStatus unknownNCT02589535
• Comparison of Total, Salivary and Calculated Free Cortisol Levels in Patients With Severe SepsisCompletedNCT02589431
• Cytokine Adsorption in Sepsis and Acute Kidney InjuryStatus unknownNCT02588794Not applicable
• Volume Therapy With Crystalloids and Colloids and Hemodynamic Monitoring in Patients With Severe SepsisWithdrawnNCT02587078Phase 4
• Neurological Consequences of Perinatal Listeriosis InfectionCompletedNCT02580812Not applicable
• Evaluation of MiSeq for Microbial Identification in SpecimensCompletedNCT02578875
• Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe SepsisTerminatedNCT02576457Phase 1
• Neutrophil Extracellular Traps and Neonatal (PV4991) & Pediatric Sepsis (PV5063)Status unknownNCT02567305
• Volemic Resuscitation in Sepsis and Septic ShockStatus unknownNCT02565251Not applicable
• Platelet REactivity in Sepsis Syndrome (PRESS)CompletedNCT02562261
• The Relation Between the Renal Resistive Index and Glomerular Hyper FiltrationCompletedNCT02560402
• Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of SepsisCompletedNCT02544490
• Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe SepsisCompletedNCT02539147
• Evaluation of the Heparin Binding Protein Levels in SepsisCompletedNCT02533011
• Diagnostic Breath Analysis Study to Detect SepsisCompletedNCT02532959
• The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of PracticeCompletedNCT02516514Not applicable
• Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in ChildrenStatus unknownNCT02515201Phase 4
• Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset SepsisCompletedNCT02503761Phase 3
• Infection, Sepsis and Meningitis in Surinamese NeonatesCompletedNCT02486783
• Ultrasound Diaphragmatic Thickening to Monitor Its Dysfunction in Patients With SepsisCompletedNCT02474797Not applicable
• Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic ShockCompletedNCT02473263Phase 3
• Modulation of Gut Microbiota in Early Sepsis: A Pilot StudyCompletedNCT02469571Not applicable
• Evaluating the Effects of SMS Text Messaging Support System Among Frontline Health Workers in GhanaCompletedNCT02468310Not applicable
• Project 4B: Lower Extremity Strength Training in ICU PatientsCompletedNCT02467023Not applicable
• Endotoxin Activity Assay and Microcirculation in Severe SepsisStatus unknownNCT02452138
• Epidemiology of Sepsis in ChinaCompletedNCT02448472
• Minimal Volume for a Fluid Challenge in Septic PatientsCompletedNCT02447042Not applicable
• IgM-enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe SepsisCompletedNCT02444871
• Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of VancomycinStatus unknownNCT02443064Phase 4
• Abdominal SepsiS Study: Epidemiology of Etiology and OutcomeCompletedNCT02442596
• A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy SubjectsCompletedNCT02439359Phase 1
• Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial ResponseCompletedNCT02437045Phase 4
• Microcirculatory Oxygen Uptake in SepsisCompletedNCT02430142
• Sepsis Assessment in Belgian Emergency RoomsTerminatedNCT02424721

← Sepsis overview